The revised guidelines also will lead to more than $20 million in extra health care costs, the research shows.
Subscribe to The Post Most newsletter for the most important and interesting stories from The Washington Post. The Trump ...
Researchers found that the decision to delay the once-universal hepatitis B shot for babies will likely cause a surge in ...
New research warns that missing the hepatitis B vaccine at birth sharply reduces the likelihood of infants completing the full series, raising future infection risks. The findings come as the CDC’s ...
The Trump administration’s recommendation against universal hepatitis B vaccination for babies on the day they’re born could ...
The decision by the Center for Disease Control and Prevention to stop recommending giving infants a dose of the hepatitis B ...
The World Health Organization (WHO) released a new report on hepatitis today, marking the World Hepatitis Summit. Since 2015, ...
Policy that recommends offering hep B vaccine at birth only to babies perceived to be at risk will lead to increased numbers ...
GSK today announced that it has filed a new drug submission for bepirovirsen for regulatory review in Canada. Bepirovirsen is ...
Phase 3 trial results demonstrate that bepirovirsen significantly increases the proportion of patients achieving functional cure compared with placebo.
New studies warn delaying the hepatitis B birth dose could leave more babies vulnerable to infection and long-term illness.
Hepatitis affects 287 million globally, often undetected until severe liver damage, says the WHO. Early testing, awareness, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results